A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: In vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities

AIDS Research and Human Retroviruses

Volumn 12, Issue 15, 1996, Pages 1463-1471

  Hayashi, Kyoko ^a   Hayashi, Toshimitsu ^a   Kojima, Ichiro ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN ENERGY CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CALCIUM; CALCIUM SPIRULAN; CD4 ANTIGEN; DEXTRAN SULFATE; POLYSACCHARIDE SULFATE; SODIUM; UNCLASSIFIED DRUG;

ALGA; ANIMAL CELL; ANIMAL MODEL; ANTICOAGULATION; ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CHELATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HELA CELL; HELPER CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNCYTIUM; VIRUS INFECTION; VIRUS INHIBITION; VIRUS PLAQUE;

EID: 0029823383     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1463     Document Type: Article

References (36)

1. Ueno R and Kuno S: Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine. Lancet 1987;1:1379.
2. Ito M, Baba M, Sato A, Pauwels R, De Clercq E, and Shigeta S: Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res 1987;7:361-367.
3. + cells. Science 1988; 240:646-649.
4. Baba M, Pauwels R, Balzarini J, Amout J, Desmyter J, and De Clercq E: Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 1988;85:6132-6136.
5. Baba M, Snoeck R, Pauwels R, and De Clercq E: Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother 1988;32:1742-1745.
6. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilliger E, Dayton A, Rosen C, Halseltine W, and Sodroski J: Functional regions of the enveloped glycoprotein of human immunodeficiency virus type 1. Science 1987;237:1351-1355.
7. Nakashima H, Yoshida O, Baba M, De Clercq E, and Yamamoto N: Anti-HIV activity of dextran sulphate as determined under different experimental conditions. Antiviral Res 1989;11:233-246.
8. + cells. J AIDS 1989;2:10-15.
9. Bagastra O and Lischner HW: Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J Infect Dis 1988;158:1084-1087.
10. Baba M, Schols D, De Clercq E, Pauwels R, Nagy M, Györgyi-Edelényi J, Löw M, and Görög S: Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation. Antimicrob Agents Chemother 1990;34:134-138.
11. Lorentsen KJ, Hendrix CW, Collins JM, Kornhauser DM, Petty BG, Klecker RW, Flexner C, Eckel RH, and Leitman PS: Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med 1989;111:561-566.
12. Hartman NR, Johns DG, and Mitsuya H: Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection. AIDS Res Hum Retroviruses 1990;6:805-812.
13. Mathes LE, Hayes KA, Swenson CL, Polas PJ, Weisbrode SE, and Kociba GJ: Evaluation of antiviral activity and toxicity of dextran sulfate in feline leukemia virus-infected cats. Antimicrob Agents Chemother 1992;35:2147-2150.
14. Koizumi N, Sakagami H, Utsumi A, Fujinaga S, Takeda M, Asano K, Sugawara I, Ichikawa S, Kondo H, Mori S, Miyatake K, Nakano Y, Nakashima H, Murakami T, Miyano N, and Yamamoto N: Anti-HIV (human immunodeficiency virus) activity of sulfated paramylon. Antiviral Res 1993;21:1-14.
15. Hayashi K, Hayashi T, Morita N, and Kojima I: An extract from Spirulina platensis is a selective inhibitor of herpes simplex virus type 1 penetration into HeLa cells. Phytother Res 1993;7:76-80.
16. Hayashi T, Hayashi K, Maeda M, and Kojima I: Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996;59:83-87.
17. Rosenberg L, Choi HU, Tang L-H, Pal S, Johnson T, Lyons DA, and Laue TM: Proteoglycans of bovine articular cartilage. J Biol Chem 1991;266:7016-7024.
18. Dubois M, Gilles KA, Hamilton JK, Rebers PA, and Smith F: Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-356.
19. Miyoshi I, Taguchi H, Kubonishi I, Yoshimoto S, Ohtsuki Y, Shiraishi Y, and Akagi T: Type C virus-producing cell lines derived from adult T cell leukemia. Gann Monogr 1982;28:219-228.
20. Kikukawa R, Koyanagi Y, Harada S, Kobayashi N, Hatanaka M, and Yamamoto N: Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol 1986;57:1159-1162.
21. Koyanagi Y, Harada S, and Yamamoto N: Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4. Cancer Lett 1986;30:299-310.
22. Hayashi K, Hayashi T, and Morita N: Mechanism of action of the antiherpesvirus biflavone ginkgetin. Antimicrob Agents Chemother 1992;36:1890-1893.
23. Reed LJ and Muench H: A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-497.
24. Anand R, Nayyar S, Galvin TA, Merril CR, and Bigelow LB: Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement. AIDS Res Hum Retroviruses 1990;6:679-689.
25. Hosoya M, Neyts J, Yamamoto N, Schols D, Snoeck R, Pauwels R, and De Clercq E: Inhibitory effects of polycations on the replication of enveloped viruses (HIV, HSV, CMV, RSV, influenza A virus and togaviruses) in vitro. Antiviral Chem Chemother 1991;2:243-248.
26. Schols D, De Clercq E, Balzarini J, Baba M, Witvrouw M, Hosoya M, Andrei G, Snoeck R, Pauwels R, Nagy M, Györgyi-Edelényi J, Machovich R, Horváth I, Löw M, and Görög S: Sulfated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena-and retro-viruses. Antiviral Chem Chemother 1990;4:233-240.
27. Witvrouw M, Schols D, Andrei G, Snoeck R, Hosoya M, Pauwels R, Balzarini J, and De Clercq E: Antiviral activity of low-MW dextran sulfate (derived from dextran MW 1,000) compared to dextran sulfate samples of higher MW. Antiviral Chem Chemother 1991;2:171-179.
28. Witvrouw M, Schols D, Andrei G, Snoeck R, Ikeda S, Pauwels R, Van Schepdael A, Araout J, Claes P, Desmyter J, and De Clercq E: New polyacetal polysulfate active against human immunodeficiency viras and other enveloped viruses. Antiviral Chem Chemother 1992;3:351-360.
29. Tyms AS, Taylor DL, and Parkin JM: Cytomegalovirus and the acquired immunodeficiency syndrome. J Antimicrob Chemother 1989;23 (Suppl A):89-105.
30. Macher AM, Reichert CM, Straus SE, Longo DL, Parrillo J, Lane HC, Fauci AS, Rook AH, Manischewitz JF, and Quinnan GV Jr: Death in the AIDS patient: Role of cytomegalovirus. N Engl J Med 1983;309:1454.
31. Witvrouw M, Desmyter J, and De Clercq E: Antiviral portrait series. 4. Polysulfates as inhibitors of HIV and other enveloped viruses. Antiviral Chem Chemother 1994;5:345-359.
32. Bagastra O, Whittle P, Heins B, and Pamerantz RJ: Anti-human immunodeficiency virus type 1 activity of sulfated monosaccharide: Comparison with sulfated polysaccharides and other polyions. J Infect Dis 1991;164:1082-1090.
33. Gonzalez ME, Alarcon B, and Carrasco L: Polysaccharides as antiviral agents: Antiviral activity of carrageenan. Antimicrob Agents Chemother 1987;31:1388-1393.
34. Yoshida O, Nakashima H, Yoshida T, Kaneko Y, Yamamoto I, Matsuzaki K, Uryu T, and Yamamoto N: Sulfation of the immunomodulating polysaccharide lentinan: A novel strategy for antivirals to human immunodeficiency virus (HIV). Biochem Pharmacol 1988;37:2887-2891.
35. Handa A, Hoshino H, Nakajima K, Adachi M, Ikeda K, Achiwa K, Itoh T, and Suzuki Y: Inhibition of infection with human immunodeficiency virus type 1 by sulfated gangliosides. Biochem Biophys Res Commun 1991;175:1-9.
36. Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gorter R, and Ueno R: Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med 1989;110:183-188.